Day: February 25, 2021

Early Warning Report Moneta Porcupine Mines Inc.

Written by Customer Service on February 25, 2021. Posted in Public Companies.

TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) — In accordance with regulatory requirements, Dundee Corporation (TSX: DC.A) (“Dundee”) announces that following closing of the transactions described in the news release issued by Moneta Porcupine Mines Inc. (the “Issuer”) dated February 24, 2021 (the “Transactions”), Dundee’s position in the Issuer has been diluted.Dundee and its affiliates own or control 40,081,000 common shares and warrants exercisable for the purchase of 2,148,975 common shares of the Issuer. Immediately prior to the Transactions, Dundee and its affiliates owned or controlled 10.15% of the Issuer on an undiluted basis and 10.63% on a partially diluted basis. Following the Transactions, Dundee owns 7.24% of the Issuer on an undiluted basis and 7.60% on a partially diluted basis.Dundee’s ownership or control of securities...

10x Genomics to Present at the 41st Annual Cowen Health Care Conference

Written by Customer Service on February 25, 2021. Posted in Public Companies.

PLEASANTON, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming 41st Annual Cowen Health Care Conference.10x Genomics’ management is scheduled to present on Wednesday, March 3 at 2 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.10xgenomics.com/.About 10x Genomics10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers...

Berkeley Lights to Participate in the Cowen 41st Annual Healthcare Conference

Written by Customer Service on February 25, 2021. Posted in Public Companies.

EMERYVILLE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming Cowen 41st Annual Healthcare Conference.Berkeley Lights’ management is scheduled to participate in a fireside chat on Thursday, March 4 at 11:10 a.m. Pacific Time / 2:10 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.berkeleylights.com.About Berkeley LightsBerkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic...

Albireo Reports Q4 and Year-End 2020 Financial Results and Business Update

Written by Customer Service on February 25, 2021. Posted in Earnings Releases And Operating Results.

– NDA and MAA for odevixibat accepted, on track for anticipated H2 21 launch –– Announces odevixibat co-promotion agreement with Travere, a leading rare disease company –– ASSERT global pivotal Phase 3 trial in Alagille syndrome initiated and enrolling –– BOLD global pivotal Phase 3 study in biliary atresia initiated and enrolling –– Pipeline expansion with two new lead compounds in adult cholestatic and viral liver diseases –– Company to host a conference call and webcast today at 10:00 a.m. ET –BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare pediatric liver disease company developing novel bile acid modulators, today provided a business update and reported financial results for the fourth quarter and year ended December 31, 2020.“2020 was a tremendous year as we delivered...

Pacira BioSciences Reports Full-Year and Fourth Quarter 2020 Financial Results

Written by Customer Service on February 25, 2021. Posted in Earnings Releases And Operating Results.

— Reports record full-year 2020 revenue of $429.6 million —— Anesthesia-driven regional approaches expanding and driving strong EXPAREL growth —— Conference call today at 8:30 a.m. ET —PARSIPPANY, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the fourth quarter and full-year of 2020.“Our nation’s opioid crisis has escalated under the shadow of the COVID-19 pandemic, as isolation and lack of access to healthcare has exacerbated mental health challenges, particularly addiction. I am delighted to report that EXPAREL-based protocols are expanding opioid-sparing pain management for a variety of procedures where historically poor postsurgical pain management fueled...

MannKind Corporation Reports 2020 Fourth Quarter and Full Year Financial Results

Written by Customer Service on February 25, 2021. Posted in Earnings Releases And Operating Results.

Conference Call to Begin Today at 9:00 AM ET4Q 2020 Afrezza Net Revenue of $10.1 million; +30% vs. 4Q 2019 • Sequential Quarter Growth +38% vs. 3Q 20202020 Total Revenues of $65.1 million • 2020 Afrezza Net Revenue of $32.3 million; +28% vs. 2019 • 2020 Afrezza Gross Profit $17.2 million; 53% Gross Margin$67.2 million of Cash, Cash Equivalents and Restricted Cash at December 31, 2020Acquired QrumPharma Inc. for $12.8 million in cash and stockEntered into an agreement to co-promote Thyquidity beginning 1Q 2021WESTLAKE VILLAGE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — MannKind Corporation (NASDAQ:MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2020.“Our fourth quarter produced exceptional results, with $10.1 million in Afrezza net revenue and positive clinical data for Tyvaso...

Oncocyte Closes Second Investment In Razor Genomics to Complete Acquisition

Written by Customer Service on February 25, 2021. Posted in Mergers And Acquisitions.

IRVINE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, has closed its previously announced second investment in Razor Genomics (“Razor”), and now owns all of Razor’s outstanding shares. In September 2019 Oncocyte acquired the rights to develop and market Razor’s treatment stratification test, now known as DetermaRx™, Oncocyte’s lead diagnostic test, through certain agreements entered into with Razor. At that time, Oncocyte was granted an option to purchase the outstanding shares of Razor common stock, which Oncocyte agreed to exercise upon the achievement of certain milestones by Razor.On January 29, 2021, Razor informed Oncocyte that those milestones had...

AgroFresh Solutions Announces Fourth Quarter and Full Year 2020 Earnings Release Date

Written by Customer Service on February 25, 2021. Posted in Public Companies.

PHILADELPHIA, Feb. 25, 2021 (GLOBE NEWSWIRE) — AgroFresh Solutions, Inc. (Nasdaq: AGFS), a global leader in produce freshness solutions, today announced that it will release fourth quarter and full year 2020 results after the market closes on Wednesday, March 10, 2021, followed by a conference call at 4:30 p.m. ET to discuss the results.Conference CallThe Company will host a conference call and webcast on Wednesday, March 10, 2021, at 4:30 p.m. ET where members of the executive management team will discuss fourth quarter and full year 2020 results with additional comments and details. The conference call and supplemental earnings presentation will be available live over the internet through the “Events & Presentations” page of the Investor Relations section of the Company’s website at www.agrofresh.com. To participate...

Synaptics To Participate At Upcoming Investor Conferences

Written by Customer Service on February 25, 2021. Posted in Public Companies.

SAN JOSE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — Synaptics Incorporated (Nasdaq: SYNA), today announced its participation in two upcoming investor conferences.Michael Hurlston, President and CEO, will virtually present at the Morgan Stanley Technology, Media and Telecom Conference on March 3, 2021 at 10:15am EST. A live webcast of the presentation will be accessible by visiting Synaptics’ investor website at investor.synaptics.com.Jason Tsai, Head of Investor Relations, will be virtually attending Susquehanna’s Tenth Annual Technology Conference on March 9 and 10, 2021.About Synaptics IncorporatedSynaptics (Nasdaq: SYNA) is changing the way humans engage with connected devices and data, engineering exceptional experiences throughout the home, at work, in the car and on the go. Synaptics is the partner of choice for the world’s...

Chiasma to Report Fourth Quarter 2020 Results on March 4

Written by Customer Service on February 25, 2021. Posted in Public Companies.

NEEDHAM, Maine, Feb. 25, 2021 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA), a commercial stage biopharmaceutical company, today announced that it will host a conference call and live audio webcast on Thursday, March 4, 2021 at 5:00 pm Eastern Time to discuss financial results for the quarter and year ended December 31, 2020 and to provide a business update.Conference Call DetailsThursday, March 4th@ 5:00 pm Eastern TimeA live audio webcast of the call may also be accessed under “Events & Presentations” on the News & Investors section of the Company’s website, https://ir.chiasma.com/events-presentations. An archived replay of the webcast will be available on the Company’s website approximately two hours after the event. The archived webcast will be available for one year.About ChiasmaChiasma is a commercial...

Day: February 25, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals